Assyro AI

Orange Book product · Brand (NDA)

CYSTADANE

BETAINE

Brand (NDA)NDA 020576TE ABRX RECORDATI RARE

At a glance

Oct 25, 1996

Approved

Brand (NDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 25, 1996

    30 yr 1 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

BETAINE

Strength

1GM/SCOOPFUL

Dosage form

FOR SOLUTION

Route

ORAL

TE code

AB

Application

NDA 020576

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.